Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk. (Q36461104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Maria Luigia Fazia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

1 reference

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

Current Atherosclerosis Reports

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

245-251

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions

20 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-006-0080-2

LDL stimulates chemotaxis of human monocytes through a cyclooxygenase-dependent pathway

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11883-006-0080-2

A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke

21 January 2018

1 reference

12 December 2020

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

12 December 2020

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

12 December 2020

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

1 reference

12 December 2020

Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2

1 reference

12 December 2020

Aspirin as an antiplatelet drug

1 reference

12 December 2020

Effects of COX-2 inhibitors on aortic prostacyclin production in cholesterol-fed rabbits

1 reference

12 December 2020

Roles of thromboxane A(2) and prostacyclin in the development of atherosclerosis in apoE-deficient mice

1 reference

12 December 2020

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

1 reference

12 December 2020

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

1 reference

12 December 2020

Alteration in prostacyclin and prostaglandin E2 production. Correlation with changes in human aortic atherosclerotic disease.

1 reference

12 December 2020

Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability

1 reference

12 December 2020

Coxibs and cardiovascular disease

1 reference

12 December 2020

Prevention of myocardial infarction and stroke by aspirin: different mechanisms? Different dosage?

1 reference

12 December 2020

Cyclooxygenase in biology and disease

1 reference

12 December 2020

Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans

1 reference

12 December 2020

Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice

1 reference

12 December 2020

Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

1 reference

12 December 2020

Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2

1 reference

12 December 2020

No effect of cyclooxygenase inhibition on plaque size in atherosclerosis-prone mice

1 reference

12 December 2020

Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

1 reference

12 December 2020

Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.

1 reference

12 December 2020

Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.

1 reference

12 December 2020

Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis

1 reference

12 December 2020

Transcriptional and posttranscriptional regulation of cyclooxygenase-2 expression by fluid shear stress in vascular endothelial cells

1 reference

12 December 2020

Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects

1 reference

12 December 2020

Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.

1 reference

12 December 2020

Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice

1 reference

12 December 2020

Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury?

1 reference

12 December 2020

Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice

1 reference

12 December 2020

Atherosclerosis — An Inflammatory Disease

1 reference

12 December 2020

Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity

1 reference

12 December 2020

Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery.

1 reference

12 December 2020

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal

1 reference

12 December 2020

Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids

1 reference

12 December 2020

Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

1 reference

12 December 2020

Novel determinants of plaque instability

1 reference

12 December 2020

Modulators of oxidized LDL-induced hyperadhesiveness in human endothelial cells.

1 reference

12 December 2020

Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing

1 reference

12 December 2020

Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo

1 reference

12 December 2020

Why there are two cyclooxygenase isozymes

1 reference

12 December 2020

The coxibs, selective inhibitors of cyclooxygenase-2.

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

12 December 2020

Cyclooxygenase-2 expression and inhibition in atherothrombosis

1 reference

12 December 2020

Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans

1 reference

12 December 2020

10.1007/S11883-006-0080-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16640962%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference